These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25830825)

  • 1. Primary prevention of cardiovascular disease with hormone replacement therapy.
    Schierbeck L
    Climacteric; 2015; 18(4):492-7. PubMed ID: 25830825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women.
    Korljan B; Bagatin J; Kokić S; Berović Matulić N; Barsić Ostojić S; Deković A
    Med Hypotheses; 2010 Jan; 74(1):162-3. PubMed ID: 19665311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy in peri- and postmenopause].
    Henes M; Hübner S
    Internist (Berl); 2020 Jun; 61(6):558-564. PubMed ID: 32333087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and cardioprotection: the end of the tale?
    Rosano GM; Vitale C; Silvestri A; Fini M
    Ann N Y Acad Sci; 2003 Nov; 997():351-7. PubMed ID: 14644842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T; Jaillon P
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy update. How to make sense of the new recommendations on postmenopausal hormone therapy.
    Harv Womens Health Watch; 2013 Mar; 20(7):3. PubMed ID: 23862210
    [No Abstract]   [Full Text] [Related]  

  • 13. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS; Clarkson TB; Notelovitz M
    Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of cardiovascular disease with HRT.
    Maclaran K; Stevenson JC
    Womens Health (Lond); 2012 Jan; 8(1):63-74. PubMed ID: 22171776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical issues and hormone replacement therapy.
    Harris PF
    Curr Womens Health Rep; 2002 Oct; 2(5):373-81. PubMed ID: 12215310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular health and the menopause: the gynecologist as the patients' interface.
    Arias RD
    Climacteric; 2006 Sep; 9 Suppl 1():6-12. PubMed ID: 16899438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU; Ridker PM; Manson JE
    Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postmenopausal hormone replacement therapy and the cardiovascular system].
    Yildirir A
    Turk Kardiyol Dern Ars; 2010 Mar; 38 Suppl 1():32-40. PubMed ID: 21491714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.